Drupal.behaviors.print = function(context) {window.print();window.close();}>
Tecan Licenses Molecular Dx IP from Enigma
January 11, 2011
Tecan Licenses Molecular Dx IP from Enigma
Tecan has licensed molecular diagnostics technology from Enigma Diagnostics.
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Enigma Dx Begins Clinical Trials for Flu Test on Integrated MDx Platform
April 14, 2011 / PCR Insider
Enigma and Tecan Expand OEM Pact to Develop High-Throughput MDx Platform for Third Party
January 13, 2011 / PCR Insider
GSK to Market Enigma Diagnostics' POC Respiratory Disease Tests Under New Pact
August 10, 2011 / PCR Insider
Enigma Diagnostics Taps Tecan to Make and Market Forthcoming POC Molecular Dx Platform
February 11, 2010 / PCR Insider
Tecan to Manufacture Enigma Diagnostics' Instruments
February 5, 2010 / GenomeWeb Daily News